HIGHFDA DEVICE

Tandem Diabetes Care Recalling 19 Units of t:slim X2 Insulin Pump Over RTL App Defect (2025)

Tandem Diabetes Care recalls 19 units of the t:slim X2 insulin pump with interoperable technology distributed internationally, including Israel. An app defect occurs when the phone uses a right-to-left language and can cause app-pump pairing problems and graphical defects. Patients should stop using the device immediately and follow the manufacturer’s recall instructions.

Official notice
Tandem Diabetes CareHealth & Personal CareMedical DevicesTandem t:slim Mobile AppAndroid Software Version 2.9.1t:slim X2 Insulin Pump

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
July 3, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
July 3, 2025
Hazard Level
HIGH
Brand
Tandem Diabetes Care
Category
Health & Personal Care
Sold At
Unknown
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Tandem Diabetes Care
Product type
Insulin Pump
Model numbers
Tandem t:slim Mobile App, Android Software Version 2.9.1, t:slim X2 Insulin Pump
Sold at
Unknown

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    July 3, 2025

  2. Reported by FDA DEVICE

    October 1, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

an app defect that occurs when the phone is set to a right-to-left language, which causes app-pump pairing issues and graphical defects, which can potentially lead to incorrect therapy decisions and subsequent hypoglycemia or hyperglycemia.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Tandem Diabetes Care, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

The t:slim X2 insulin pump with interoperable technology is used by people with diabetes to manage insulin delivery through a paired mobile app.

Why This Is Dangerous

A right-to-left language setting can disrupt app-pump pairing and create display errors, risking incorrect dosing decisions.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

The issue could lead to incorrect therapy decisions and potential hypo- or hyperglycemia, requiring clinical follow-up.

Practical Guidance

How to identify if yours is affected

  1. Verify you have the Tandem t:slim X2 insulin pump and the Tandem t:slim Mobile App.
  2. Check if your phone uses a right-to-left language setting.
  3. Confirm the app version is Android Version 2.9.1.
  4. Look for any pairing or graphical issues with the pump and app.

Where to find product info

Recall notice and device identifiers are provided by Tandem Diabetes Care and the FDA enforcement database.

What timeline to expect

Remediation timelines are not specified; typical recall processes may take several weeks to finalize refunds or replacements.

If the manufacturer is unresponsive

  • Document all correspondence with the manufacturer.
  • Contact your healthcare provider for interim guidance.
  • Consider filing a consumer safety complaint if the company is unresponsive.

How to prevent similar issues

  • Do not modify app settings or language during a pending recall.
  • Monitor glucose levels closely if you must continue therapy under clinician instruction.
  • Keep app and device software up to date when a confirmed safe version is released by the manufacturer.

Documentation advice

Keep the recall notice, device serial numbers, app version, and all correspondence with the manufacturer for records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: Tandem t:slim Mobile App; Android Software Version 2.9.1; t:slim X2 Insulin Pump. Where sold: International distribution, including Israel. When sold: Unknown. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Distribution: International, including Israel
  • Models affected: Tandem t:slim Mobile App; Android Software Version 2.9.1
  • Hazard: RTL-language app defect causing pairing issues and display errors

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Tandem t:slim Mobile App
Android Software Version 2.9.1
t:slim X2 Insulin Pump
Report Date
October 1, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more